11 research outputs found

    Methanotrophy, Methylotrophy, the Human Body and Disease

    Get PDF
    Methylotrophic Bacteria use one-carbon (C1) compounds as their carbon source. They have been known to be associated to the human body for almost 20 years as part of the normal flora and were identified as pathogens in the early 1990s in end-stage HIV patients and chemotherapy patients. In this chapter, I look at C1 compounds in the human body and exposure from the environment and then consider Methylobacterium spp. and Methylorubrum spp. in terms of infections, its role in breast and bowel cancers; Methylococcus capsulatus and its role in inflammatory bowel disease, and Brevibacterium casei and Hyphomicrobium sulfonivorans as part of the normal human flora. I also consider the abundance of methylotrophs from the Actinobacteria being identified in human studies and the potential bias of the ionic strength of culture media and the needs for future work. Within the scope of future work, I consider the need for the urgent assessment of the pathogenic, oncogenic, mutagenic and teratogenic potential of Methylobacterium spp. and Methylorubrum spp. and the need to handle them at higher containment levels until more data are available

    Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis

    No full text
    In this study, we sought to find novel bacterial and metabolic hallmarks for bacterial vaginosis (BV). We studied the vaginal microbiome and metabolome of vaginal fluids from BV-affected patients (n = 43) and healthy controls (n = 37) by means of an integrated approach based on quantitative polymerase chain reaction (qPCR) and proton nuclear magnetic resonance ((1)H-NMR). The correlations between the clinical condition and vaginal bacterial communities were investigated by principal component analysis (PCA). To define the metabolomics signatures of BV, 100 discriminant analysis by projection on latent structure (PLS-DA) models were calculated. Bacterial signatures distinguishing the health condition and BV were identified by qPCR. Lactobacillus crispatus strongly featured the healthy vagina, while increased concentrations of Prevotella, Atopobium and Mycoplasma hominis specifically marked the infection. (1)H-NMR analysis has led to the identification and quantification of 17 previously unreported molecules. BV was associated with changes in the concentration of metabolites belonging to the families of amines, organic acids, short chain fatty acids, amino acids, nitrogenous bases and monosaccharides. In particular, maltose, kynurenine and NAD(+) primarily characterised the healthy status, while nicotinate, malonate and acetate were the best metabolic hallmarks of BV. This study helps to better understand the role of the vaginal microbiota and metabolome in the development of BV infection. We propose a molecular approach for the diagnosis of BV based on quantitative detection in the vaginal fluids of Atopobium, Prevotella and M. hominis, and nicotinate, malonate and acetate by combining qPCR and (1)H-NMR

    Individual variation in body odor

    No full text
    Humans produce numerous volatile compounds from different areas of the body, either as a direct result of metabolic processes or indirectly via metabolismof resident microflora. Body odors vary between individuals, partly due to genetic differences, but odors of the same individual also vary across time due to environmental influences. We discuss how at least part of the genetic influence appears to be related to certain personality characteristics and to sexual orientation. We then review the current state of the art in terms of intraindividual variation, including effects of intrinsic factors, such as hormonal influences on body odor and environmental factors, namely effects of diet and certain diseases. Some of these changes can be perceived by other individuals and might therefore provide social cues of current motivational, nutritional, and health status. Finally, we discuss how specific odor profiles associated with certain infectious diseases and metabolic disorders can be used as a cheap and efficient medical screening tool

    Biomarkers of urinary tract infections: state of the art, and promising applications for rapid strip-based chemical sensors

    No full text
    corecore